Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed)

The summary for the Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed): This PAR seeks applications from eligible Small Business Concerns (SBCs) for the development of informatics tools with commercial potential to facilitate uptake and scientific use of the human pangenome reference being developed and maintained by the NHGRI Human Genome Reference Program (HGRP). This PAR specifically calls for innovative Phase I STTR applications from SBCs to demonstrate proof of principle or viability of informatics tools for use of the human pangenome. Emphasis will be on the development of tools to advance compelling use cases that are relevant to different broad sectors of the genomics community, e.g., clinical, population, and functional genomics.

Federal Grant Title:	Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-25-309
Type of Funding:	Grant
CFDA Numbers:	93.172
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 3rd, 2025
Original Application Deadline:	March 3rd, 2025
Posted Date:	December 10th, 2024
Creation Date:	December 10th, 2024
Archive Date:	April 8th, 2025
Total Program Funding:
Maximum Federal Grant Award:	$400,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	December 10th, 2024

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/pa-files/PAR-25-309.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • GREGoRi Innovation Projects (U01 Clinical Trial Optional); • GREGoRi Technology Integration Center (U01, Clinical Trials Optional); • GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed); • Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Sch...; • Single Source: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk A...; • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44); • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42); • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health: • Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial...; • Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VC...; • Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional); • Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal ...; • PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine...